These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2155977)

  • 1. Immunogenicity of hepatitis A virus vaccine in primates.
    Chaudhary RK; Mo T
    J Infect Dis; 1990 Mar; 161(3):586-7. PubMed ID: 2155977
    [No Abstract]   [Full Text] [Related]  

  • 2. Inactivated virosome hepatitis A vaccine.
    D'Hondt E; Delem A
    Lancet; 1994 May; 343(8906):1165-6. PubMed ID: 7910259
    [No Abstract]   [Full Text] [Related]  

  • 3. Reactogenicity and immunogenicity of three different lots of a hepatitis A vaccine.
    Theilmann L; Kallinowski B; Gmelin K; Hofmann F; Scheiermann N; Wohland B; Stickl H; Maiwald H; Moriabadi FK; Bock HL
    Vaccine; 1992; 10 Suppl 1():S132-4. PubMed ID: 1335644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivated hepatitis A vaccine: a safety and immunogenicity study in health professionals.
    Davidson M; Krugman S; Sandman LA
    Vaccine; 1992; 10 Suppl 1():S119-20. PubMed ID: 1335639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity trial of inactivated hepatitis A virus vaccine in human volunteers.
    Kusov YuYu ; Elbert LB; Nelga IV; Grishina GK; Dunaevski OA; Kharin NV; Maslov YuN ; Drozdov SG; Balayan MS
    Vaccine; 1991 Aug; 9(8):540-1. PubMed ID: 1663301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivated hepatitis A virus vaccines.
    Lemon SM
    Hepatology; 1992 Jun; 15(6):1194-7. PubMed ID: 1317341
    [No Abstract]   [Full Text] [Related]  

  • 7. A redoubtable obstacle to a hepatitis C vaccine.
    Koff RS
    Gastroenterology; 1993 Apr; 104(4):1228-9. PubMed ID: 8385045
    [No Abstract]   [Full Text] [Related]  

  • 8. Reactogenicity and immunogenicity of inactivated hepatitis A vaccines.
    Just M; Berger R
    Vaccine; 1992; 10 Suppl 1():S110-3. PubMed ID: 1362031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis A vaccination: schedule for accelerated immunization.
    Müller R; Chriske H; Deinhardt F; Jilg J; Theilmann L; Hess G; Hofmann F; Hopf U; Stickl H; Maiwald H
    Vaccine; 1992; 10 Suppl 1():S124-5. PubMed ID: 1335641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic approaches to assessing the response to inactivated hepatitis A vaccine.
    Lemon SM
    J Hepatol; 1993; 18 Suppl 2():S15-9. PubMed ID: 8182266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of vaccine-induced antibody to hepatitis A virus.
    Wiedermann G; Ambrosch F; André FE; D'Hondt E; Delem A; Safary A
    Vaccine; 1992; 10 Suppl 1():S129-31. PubMed ID: 1335643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production, quality control and characterization of an inactivated hepatitis A vaccine.
    Peetermans J
    Vaccine; 1992; 10 Suppl 1():S99-101. PubMed ID: 1335671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of hepatitis A vaccination schedules on immune response.
    Tilzey AJ; Palmer SJ; Barrow S; Perry KR; Tyrell H; Safary A; Banatvala JE
    Vaccine; 1992; 10 Suppl 1():S121-3. PubMed ID: 1335640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of hepatitis A vaccine in healthy adult volunteers.
    Horng YC; Chang MH; Lee CY; Safary A; Andre FE; Chen DS
    J Gastroenterol Hepatol; 1993; 8(4):338-41. PubMed ID: 8397010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory tests and reference reagents employed in studies of inactivated hepatitis A vaccine.
    Binn LN; MacArthy PO; Marchwicki RH; Sjogren MH; Hoke CH; Burge JR; D'Hondt E
    Vaccine; 1992; 10 Suppl 1():S102-5. PubMed ID: 1335636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of an inactivated hepatitis A vaccine in Alaska Native children and Native and non-Native adults.
    McMahon BJ; Williams J; Bulkow L; Snowball M; Wainwright R; Kennedy M; Krause D
    J Infect Dis; 1995 Mar; 171(3):676-9. PubMed ID: 7876615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The specific safety of a cultured inactivated vaccine against hepatitis A].
    Kusov IuIu; Orlova TM; Panina LI; Kazachkov IuA; Nel'ga IV; El'bert LB; Krutianskaia GL; Poleshchuk VF; Sobol' AV; Titova IP
    Vopr Virusol; 1991; 36(2):156-9. PubMed ID: 1652870
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunogenicity of a hepatitis A virus vaccine.
    Flehmig B; Haage A; Pfisterer M
    J Med Virol; 1987 May; 22(1):7-16. PubMed ID: 3035082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of an inactivated hepatitis A vaccine in healthy children: two years' follow-up.
    Lee WT; Chang MH; Lee CY; Chen DS; Safary A; Andre FE
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1995; 36(5):331-5. PubMed ID: 8607357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release potency tests of hepatitis vaccines.
    Descamps J; Mary A; Rommel E; Anhoury ML; De Neys R; Duchêne M
    Dev Biol Stand; 1999; 101():289-94. PubMed ID: 10566803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.